Importer of Controlled Substances Registration, 45519 [2019-18685]
Download as PDF
<![CDATA[
45519
Federal Register / Vol. 84, No. 168 / Thursday, August 29, 2019 / Notices
granted a registration as an importer for
schedule II controlled substances to the
above listed companies.
DEPARTMENT OF JUSTICE
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[Docket No. DEA–392]
Administration (DEA) as importers of
schedule I and II controlled substances.
Drug Enforcement Administration
Importer of Controlled Substances
Registration
[FR Doc. 2019–18686 Filed 8–28–19; 8:45 am]
ACTION:
BILLING CODE 4410–09–P
Notice of registration.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
SUMMARY:
The
companies listed below applied to be
registered as an importers of various
basic classes of schedule I and II
controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
SUPPLEMENTARY INFORMATION:
Companies
Unither Manufacturing, LLC .................................................................................................................................
Shertech Laboratories, LLC .................................................................................................................................
khammond on DSKBBV9HB2PROD with NOTICES
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule II controlled substances to the
above listed companies.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
FR docket
Published
84 FR 13961
84 FR 26446
April 8, 2019.
June 6, 2019.
The registrants listed below
have applied for and been granted
registration by the Drug Enforcement
Administration (DEA) as importers of
schedule I and II controlled substances.
SUMMARY:
The
companies listed below applied to be
registered as an importers of various
basic classes of schedule I and II
controlled substances. Information on
previously published notices is listed in
the table below. No comments or
objections were submitted and no
requests for a hearing were submitted
for these notices.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2019–18688 Filed 8–28–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
Companies
FR docket
United States Pharmacopeial Convention .......................................................................................
Bellwyck Clinical Services ...............................................................................................................
84 FR 23582 .............
84 FR 31622 .............
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable various basic classes of
schedule I and II controlled substances
is consistent with the public interest
and with United States obligations
under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated each
of the company’s maintenance of
effective controls against diversion by
inspecting and testing each company’s
physical security systems, verifying
each company’s compliance with state
and local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
VerDate Sep<11>2014
17:00 Aug 28, 2019
Jkt 247001
granted a registration as an importer for
schedule I and II controlled substances
to the above listed companies.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019–18685 Filed 8–28–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Published
May 22, 2019.
July 2, 2019.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 28, 2019.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on July 15, 2019, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402 applied
to be registered as a bulk manufacturer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
ACTION:
PO 00000
Notice of application.
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\29AUN1.SGM
29AUN1
]]>Agencies
[Federal Register Volume 84, Number 168 (Thursday, August 29, 2019)]
[Notices]
[Page 45519]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-18685]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: The registrants listed below have applied for and been granted
registration by the Drug Enforcement Administration (DEA) as importers
of schedule I and II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as an importers of various basic classes of schedule I and
II controlled substances. Information on previously published notices
is listed in the table below. No comments or objections were submitted
and no requests for a hearing were submitted for these notices.
----------------------------------------------------------------------------------------------------------------
Companies FR docket Published
----------------------------------------------------------------------------------------------------------------
United States Pharmacopeial Convention........ 84 FR 23582.................... May 22, 2019.
Bellwyck Clinical Services.................... 84 FR 31622.................... July 2, 2019.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable various basic classes of schedule I and II
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each of the
company's maintenance of effective controls against diversion by
inspecting and testing each company's physical security systems,
verifying each company's compliance with state and local laws, and
reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I and II controlled substances to the above
listed companies.
Dated: August 16, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18685 Filed 8-28-19; 8:45 am]
BILLING CODE 4410-09-P
